| Sources | Names Used |
|---|---|
| CTRPv2 | Repligen 136 |
| PharmacoGx | Repligen 136 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | GSDMB | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | ZNF711 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | FRAT2 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | FGF4 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | FRAT1 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | TAAR6 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | CHD4 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | FCGR2A | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | LEPR | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
